PHASE I/II TRIAL OF TUMOR LYSATE PULSED DENDRITIC CELL VACCINE WITH A TOLL-LIKE RECEPTOR 7 (TLR7) AGONIST FOR PATIENTS WITH GLIOBLASTOMA

被引：0
|
作者：
Yu, John [1 ]
Rudnick, Jeremy [1 ]
Hu, Jethro [1 ]
Phuphanich, Surasak [1 ]
Mazer, Mia [1 ]
Wang, Hongqiang [1 ]
Xu, Minlin [1 ]
Nuno, Miriam [1 ]
Patil, Chirag [1 ]
Chu, Ray [1 ]
Black, Keith [1 ]
Wheeler, Chris [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [31] Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens
    Philbin, VJ
    Iqbal, M
    Boyd, Y
    Goodchild, MJ
    Beal, RK
    Bumstead, N
    Young, J
    Smith, AL
    IMMUNOLOGY, 2005, 114 (04) : 507 - 521
  • [32] Involvement of toll-like receptor 7 (TLR7) in the pathogenesis of HSV-1 induced acute retinal necrosis
    Zheng, M
    Li, H
    Qian, H
    Fields, MA
    Yu, F
    Atherton, SS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U596 - U596
  • [33] Characterization, evolution and expression analysis of Toll-like receptor 7 (TLR7) in turbot (Scophthalmus maximus L.)
    Wang, Beibei
    Liu, Xiaoli
    Zhao, Jing
    Cao, Min
    Yu, Zhouxin
    Fu, Qiang
    Tan, Fenghua
    Yang, Ning
    Li, Chao
    FISH & SHELLFISH IMMUNOLOGY, 2022, 125 : 9 - 16
  • [34] A phase 2 study of EIK1001, a Toll-like receptor 7/8 (TLR7/8) agonist, in combination with pembrolizumab and chemotherapy in patients with stage 4 non-small cell lung cancer
    Costin, Dan
    Chen, Kevin
    Gralla, Richard J.
    Garofalo, Brage
    Wang, Meihua
    Kurland, Etah
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Necrotizing lymphadenitis may be induced by overexpression of Toll-like receptor7 (TLR7) caused by reduced TLR9 transport in plasmacytoid dendritic cells (PDCs)
    Asano, Shigeyuki
    Sato, Hiroko
    Mori, Kikuo
    Yamazaki, Kazuki
    Naito, Hiroyuki
    Suzuki, Hoshiro
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2021, 61 (02) : 85 - 92
  • [36] Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors
    Gilliet, M
    Conrad, C
    Geiges, M
    Cozzio, A
    Thürlimann, W
    Burg, G
    Nestle, FO
    Dummer, R
    ARCHIVES OF DERMATOLOGY, 2004, 140 (12) : 1490 - 1495
  • [37] Autologous tumor-lysate pulsed dendritic cell vaccination, together with the TLR-7 agonist 5% imiquimod, and serum pro-inflammatory cytokine levels in glioblastoma patients
    Prins, R. M.
    Odesa, S.
    Soto, H.
    Yong, W. H.
    Lai, A.
    Bosch, M.
    Boynton, A.
    Cloughesy, T. F.
    Liau, L. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists for resected stage IIB-IV melanoma.
    Patel, Sapna Pradyuman
    Petroni, Gina R.
    Gaughan, Elizabeth Mary
    Grosh, William W.
    Gnjatic, Sacha
    Hwu, Patrick
    Slingluff, Craig L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Vesicular Stomatitis Virus M Protein Mutant Stimulates Maturation of Toll-Like Receptor 7 (TLR7)-Positive Dendritic Cells through TLR-Dependent and -Independent Mechanisms
    Ahmed, Maryam
    Mitchell, Latoya M.
    Puckett, Shelby
    Brzoza-Lewis, Kristina L.
    Lyles, Douglas S.
    Hiltbold, Elizabeth M.
    JOURNAL OF VIROLOGY, 2009, 83 (07) : 2962 - 2975
  • [40] Necrotising lymphadenitis might be induced by over expression of Toll-like receptor7(TLR7) caused by reduction of TLR9 transport in plasmacytoid dendritic cells (PDCs)
    Asano, S.
    Sato, H.
    Naito, H.
    Yamazaki, K.
    Mori, K.
    Wakasa, H.
    Suzuki, H.
    VIRCHOWS ARCHIV, 2019, 475 : S89 - S89
12345